Geneva Capital Management LLC Decreases Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Geneva Capital Management LLC trimmed its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 0.2% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 494,710 shares of the company’s stock after selling 1,140 shares during the quarter. Geneva Capital Management LLC owned 1.01% of Azenta worth $23,964,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Hantz Financial Services Inc. purchased a new position in shares of Azenta during the 2nd quarter worth about $30,000. Farther Finance Advisors LLC boosted its position in shares of Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after buying an additional 256 shares during the period. Benjamin F. Edwards & Company Inc. grew its stake in shares of Azenta by 150.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after buying an additional 955 shares during the last quarter. Lazard Asset Management LLC purchased a new stake in shares of Azenta in the first quarter worth approximately $130,000. Finally, Acadian Asset Management LLC lifted its stake in shares of Azenta by 24.7% during the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock worth $143,000 after acquiring an additional 471 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on AZTA. Evercore ISI reduced their target price on Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Needham & Company LLC reaffirmed a “buy” rating and issued a $69.00 price target on shares of Azenta in a research note on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $66.40.

Insider Activity

In related news, CFO Herman Cueto sold 1,595 shares of the company’s stock in a transaction dated Thursday, October 17th. The shares were sold at an average price of $43.68, for a total value of $69,669.60. Following the completion of the sale, the chief financial officer now directly owns 24,604 shares of the company’s stock, valued at $1,074,702.72. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.77% of the company’s stock.

Azenta Stock Up 0.3 %

Shares of NASDAQ AZTA opened at $45.99 on Wednesday. Azenta, Inc. has a twelve month low of $40.24 and a twelve month high of $69.16. The business has a fifty day simple moving average of $45.83 and a two-hundred day simple moving average of $50.64.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.